Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Insulet (Omnipod AI)
InsuletInsulet (Omnipod AI) Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
What is becoming different about Insulet (Omnipod AI) over time?
Public evidence
Insulet raises revenue expectations for 2026
MedTech Dive
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 4 public external signal(s) across 1 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Insulet (Omnipod AI) through regulatory records, deployment evidence, company records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand Insulet (Omnipod AI). As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Omnipod 5 is a tubeless insulin delivery system that integrates with continuous glucose monitors and smartphones. The system automatically adjusts insulin delivery every five minutes based on glucose readings.According to Insulet
What Insulet states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The system automatically adjusts insulin delivery every five minutes based on CGM readings.
According to Insulet
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
Top medtech stories from ADA’s Scientific Sessions
According to MedTech Dive
How widely is this actually used?
Reported deployment
Insulet recalls 7M patch pumps due to leak risk
According to MedTech Dive
How widely is this actually used?
Reported outcome
Insulet launches Omnipod 5 in Spain
According to MedTech Dive
Are you seeing this result?
Recent change
Insulet raises revenue expectations for 2026
According to MedTech Dive
Have you noticed this shift?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
-
Product Overview: Omnipod 5 is a tubeless automated insulin delivery (AID) system designed to simplify diabetes management by integrating with continuous glucose monitors (CGMs) and smartphones.
-
Technical Functionality: The system consists of a small, waterproof Pod that delivers insulin continuously…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
Key strength
Regulatory: FDA 510(k) cleared, CE Mark
Parent Company
Insuletvendor
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Insulet (Omnipod AI) accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence